PATENT CLAIM ANALYSIS

Application Number: 15756367
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "300000"]

Abstract:
The present invention provides compounds of Formula (I): wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

Claim (Index 2):
A compound according to  claim 1 or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, or a solvate thereof, wherein: R 1  is independently selected from: H, C 1-4  alkyl substituted with 0-1 C 1-4  alkoxy, C 1-4  haloalkyl, SO 2 (C 1-4  alkyl), \u2014X 2 \u2014C 3-10  carbocycle and \u2014X 1 -(5- to 10-membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NR b , 0, and S); wherein said carbocycle and heterocycle are substituted with 0-1 R 6  and 0-2 R 7 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.26829
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15756373', '15756378', '16099010', '13944921', '13936311']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.777425965654991
- 35 USC 102 Novelty (BERT): 0.6135606521617459
- Combined Prediction Score: 0.7610394343056666
- Mean Citation Score: 444.768054
- Max Citation Score: 554.2722
- Similarity Product: 492.3139092679739

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test